Anecdotal evidence "impressive".
Scandiffio
R
R
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001569:Benzodiazepines; D003402:Creatine Kinase / Q000032:analysis* / Q000187:drug effects; D005260:Female; D006801:Humans; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use
D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D003402:Creatine Kinase; D000077152:Olanzapine